APA (7th ed.) Citation

RE, S., FL, B., J, G., M, L., L, G., C, S., . . . N, G. (2023). Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: A tertiary center study. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.., 67(3), 206. https://doi.org/10.23736/S1824-4785.22.03485-9

Chicago Style (17th ed.) Citation

RE, Sönmez, et al. "Towards Refining the Utility of Dual (18F-FDG / 18F-Choline) PET/CT for the Management of Hepatocellular Carcinoma: A Tertiary Center Study." The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.. 67, no. 3 (2023): 206. https://doi.org/10.23736/S1824-4785.22.03485-9.

MLA (9th ed.) Citation

RE, Sönmez, et al. "Towards Refining the Utility of Dual (18F-FDG / 18F-Choline) PET/CT for the Management of Hepatocellular Carcinoma: A Tertiary Center Study." The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.., vol. 67, no. 3, 2023, p. 206, https://doi.org/10.23736/S1824-4785.22.03485-9.